1MICHAEL B.C-reactive protein:a new risk assessment tool for cardiovascular disease[J].JAOA,2005,105(9):409-416.
2PEARSON T A,MENSAH G A,HONG Y,et al.For the Centers for Disease Control and Prevention and the American Heart Association Workshop on Markers of Inflammation and Cardiovascular Disease.CDC/AHA workshop on markers of inflammation and cardiovascular disease:application to clinical and public health practice:overview[J].Circulation,2004,110(25):e543-544.
3HAGE F G,SZALAI A J.C-reactive protein gene polymorphisms,c-reactive protein blood levels,and cardiovascular disease risk[J].JACC,2007,50(12):1115-1122.
4TENG M S,HSU L A,WU S.Association between C-reactive protein gene haplotypes and C-reactive protein levels in Taiwan Residents:Interaction with obesity[J].Atherosclerosis,2009,204(2):e64-e69.
5ZEE R Y,HEGENER H H,FERNANDEZ CRUZ A,et al.C-reactive protein gene polymorphisms and the incidence of postangioplasty restenosis[J].Atherosclerosis,2004,176(2):393-396.
6LANGE L A,CARLSON C S,HINDORFF L A,et al.Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events[J].JAMA,2006,296(22):2703-2711.
7SIE M P S,MATTACE RASO F U S,KARDYS I,et al.Genetic variation in the C-reactive protein gene and arterial stiffness:The Rotterdam Study[J].Artery Research,2008,2(4):148-155.
8CRAWFORD D C,SANDERS C L,QIN X,et al.Genetic variation is associated with C-reactive protein levels in the third National Health and Nutrition Examination Survey[J].Circulation,2006,114(23):2458-2465.
9SZALAI A J,WU J,LANGE E M,et al.Single-nucleotidepolymorphismsin the C-reactive protein gene promoter that affect transcription factor binding,alter transcriptional activity,and associate with differences in baseline serum CRP level[J].J Mol Med,2005,83(6):440-447.
10KHREISS T,JOZSEF L,POTEMPA L A,et al.Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells[J].Circulation,2004,109(16):2016-2022.
